Clinical Trials Logo

Clinical Trial Summary

The UltraShape® Contour I- Y system uses focused ultrasound to produce localized mechanical motion within fat tissues and cells for the purpose of producing mechanical cellular membrane disruption. It is intended for reduction in body circumference.

The primary objective of this study is to evaluate the efficacy of the Contour I - Y System on abdominal circumference reduction relative to baseline pretreatment values using different treatment methods.

The primary efficacy endpoint in this trial is Statistical Difference of Circumference reduction between Baseline measurement and at follow-up measurement.


Clinical Trial Description

n/a


Study Design

Allocation: Non-Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment


Related Conditions & MeSH terms

  • Reduction in Abdominal Circumference

NCT number NCT01609699
Study type Interventional
Source UltraShape
Contact Lior Greenbaum, PhD
Phone +972.4.909.4418
Email lior@ultrashape.com
Status Not yet recruiting
Phase N/A
Start date August 2012
Completion date December 2012